FDA approves Avastin to treat patients with aggressive and late-stage cervical cancer
Thursday, August 21, 2014
From the link:
Avastin works by interfering with the blood vessels that fuel the development of cancerous cells. The new indication for cervical cancer is approved for use in combination with chemotherapy drugs paclitaxel and cisplatin or in combination with paclitaxel and topotecan.